Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm... by Alves, Katia, Kotloff, Karen, McClelland, R Scott, Kouassi, Alex, Plested, Joyce S, Kalkeri, Raj, Zhu, MingZhu, Cloney-Clark, Shane, Cai, Zhaohui, Smith, Katherine, Kaba, Muneer, Nelson, Joy, Hammershaimb, E Adrianne, Mallory, Raburn M, Noriega, Fernando, Adelglass, Jeffrey, Akinsola, Adebayo, Alleman, Brandon, Bell, Codey, Chu, Laurence, Davis, Matthew, Fanning, Sue, Ferrera, David, Freeman, George, Gorgos, Linda, Hollister, Ripley, Jacobs, Michael, Julien, Craig, Kotloff, Karen, Lockwood, Robert, McClelland, R. Scott, McDonald, Jara, Murillo, Abel, Noveck, Robert, Pickrell, Paul, Seger, William, Slechta, Stacy, Smith, William, Studdard, Harry, Surowitz, Ronald, Tapia, Milagritos, Uribe, Eduardo, Vrbicky, Keith, Wadsworth, Larkin, Yenal, Kem, Ylisastigui, Pedro

Get full text